UVA Health
HealthFDA approves once-daily Parkinson’s pill (Juvmo) built on decades of work by husband-and-wife team
Once-daily tavapadon offers a new Parkinson’s treatment option, with symptom benefits supported by trials and important safety limits.
Mac Oliveau